BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27788759)

  • 21. Impact of HLA in cord blood transplantation outcomes.
    Ruggeri A; Paviglianiti A; Gluckman E; Rocha V
    HLA; 2016 Jun; 87(6):413-21. PubMed ID: 27060588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes from unrelated donor hematopoietic stem cell transplantation.
    Perez LE
    Cancer Control; 2011 Oct; 18(4):216-21. PubMed ID: 21976240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High resolution HLA class I and II typing and CTLp frequency in unrelated donor transplantation: a single-institution retrospective study of 69 BMTs.
    El Kassar N; Legouvello S; Joseph CM; Salesses P; Rieux C; Cordonnier C; Vernant JP; Farcet JP; Bierling P; Kuentz M
    Bone Marrow Transplant; 2001 Jan; 27(1):35-43. PubMed ID: 11244436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic transplantation from adult unrelated donors as treatment for acute myeloid leukemia.
    Sierra J; Martino R; Sánchez B; Piñana JL; Valcárcel D; Brunet S
    Bone Marrow Transplant; 2008 Mar; 41(5):425-37. PubMed ID: 18209727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dynamic Detection of Anti-Human Leukocyte Antigen (HLA) Antibodies but not HLA-DP Loci Mismatches Can Predict Acute Graft-versus-Host Disease and Overall Survival in HLA 12/12-Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies.
    Pan Z; Yuan X; Li Y; Wu X; Zhu W; Bao X; Zhao Q; He J
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):86-95. PubMed ID: 26283096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparison of clinical outcomes between unrelated donor and HLA-haploidentical donor hematopoietic stem cell transplantation].
    Chen F; Wu DP; Sun AN; Ma X; Tang XW; Qiu HY; Miao M; Fu ZZ; Jin ZM; Wang Y; Wu XJ; Chen SN; He GS; Wang XL; Xue SL; Zhao Y; Chang WR
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):83-6. PubMed ID: 18681306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
    Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
    J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-Resolution Match Rate of 7/8 and 9/10 or Better for the Be The Match Unrelated Donor Registry.
    Buck K; Wadsworth K; Setterholm M; Maiers M; Confer D; Hartzman R; Schmidt A; Yang SY; Dehn J
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):759-763. PubMed ID: 26724431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial Role of Low-Dose Antithymocyte Globulin in Unrelated Stem Cell Transplantation for Adult Patients with Acquired Severe Aplastic Anemia: Reduction of Graft-versus-Host Disease and Improvement of Graft-versus-Host Disease-Free, Failure-Free Survival Rate.
    Park SS; Kwak DH; Jeon YW; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Min WS; Lee JW
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1498-1508. PubMed ID: 28554856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcomes of HLA-DPB1 mismatches in 10/10 HLA-matched unrelated donor-recipient pairs undergoing allogeneic stem cell transplant.
    Moyer AM; Hashmi SK; Kroning CM; Kremers WK; De Goey SR; Patnaik M; Litzow M; Gastineau DA; Hogan WJ; Jacob EK; Kreuter JD; Wakefield LL; Gandhi MJ
    Eur J Haematol; 2017 Sep; 99(3):275-282. PubMed ID: 28632323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program.
    Karanes C; Nelson GO; Chitphakdithai P; Agura E; Ballen KK; Bolan CD; Porter DL; Uberti JP; King RJ; Confer DL
    Biol Blood Marrow Transplant; 2008 Sep; 14(9 Suppl):8-15. PubMed ID: 18721775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Single cord blood combined with HLA-mismatched third party donor cells: comparable results to matched unrelated donor transplantation in high-risk patients with hematologic disorders.
    Kwon M; Balsalobre P; Serrano D; Pérez Corral A; Buño I; Anguita J; Gayoso J; Diez-Martin JL
    Biol Blood Marrow Transplant; 2013 Jan; 19(1):143-9. PubMed ID: 22960386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival.
    van Besien K; Hari P; Zhang MJ; Liu HT; Stock W; Godley L; Odenike O; Larson R; Bishop M; Wickrema A; Gergis U; Mayer S; Shore T; Tsai S; Rhodes J; Cushing MM; Korman S; Artz A
    Haematologica; 2016 May; 101(5):634-43. PubMed ID: 26869630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmune hematological diseases following haploidentical donor hematopoietic stem cell Transplant compared with matched sibling and unrelated donor.
    Lv W; Fan Z; Huang F; Xu N; Xuan L; GuopanYu ; Jiang Q; Zhou H; Lin R; Zhang X; Sun J; Liu Q
    Oncotarget; 2017 Apr; 8(16):26505-26514. PubMed ID: 28460445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis.
    Bacigalupo A; Socié G; Hamladji RM; Aljurf M; Maschan A; Kyrcz-Krzemien S; Cybicka A; Sengelov H; Unal A; Beelen D; Locasciulli A; Dufour C; Passweg JR; Oneto R; Signori A; Marsh JC;
    Haematologica; 2015 May; 100(5):696-702. PubMed ID: 25616576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings.
    Szydlo R; Goldman JM; Klein JP; Gale RP; Ash RC; Bach FH; Bradley BA; Casper JT; Flomenberg N; Gajewski JL; Gluckman E; Henslee-Downey PJ; Hows JM; Jacobsen N; Kolb HJ; Lowenberg B; Masaoka T; Rowlings PA; Sondel PM; van Bekkum DW; van Rood JJ; Vowels MR; Zhang MJ; Horowitz MM
    J Clin Oncol; 1997 May; 15(5):1767-77. PubMed ID: 9164184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of HLA-matching on reduced intensity conditioning regimen unrelated donor allogeneic stem cell transplantation for acute myeloid leukemia in patients above 50 years-a report from the EBMT acute leukemia working party.
    Rubio MT; Savani BN; Labopin M; Polge E; Niederwieser D; Ganser A; Schwerdtfeger R; Ehninger G; Finke J; Renate A; Craddock C; Kröger N; Hallek M; Jindra P; Mohty M; Nagler A
    J Hematol Oncol; 2016 Aug; 9(1):65. PubMed ID: 27488518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior transplantation outcomes of 8/8-matched unrelated donors as well as matched siblings to autologous transplantation for acute myeloid leukemia with intermediate cytogenetics in first remission.
    Cho BS; Kim JH; Yoon JH; Shin SH; Yahng SA; Lee SE; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Kim HJ
    Eur J Haematol; 2013 May; 90(5):365-74. PubMed ID: 23414524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
    Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
    Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.